Interferon beta-1a Completed Phase 1 Trials for Disseminated Sclerosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02269930Study to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterferon Beta-1a) and Rebif® (Interferon Beta-1a) in Healthy Volunteers
NCT02474134Comparison Study of PF530 and Betaferon in Healthy Subjects